These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19541274)

  • 1. Repeat probing for treatment of persistent nasolacrimal duct obstruction.
    ; Repka MX; Chandler DL; Bremer DL; Collins ML; Lee DH
    J AAPOS; 2009 Jun; 13(3):306-7. PubMed ID: 19541274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
    ; Repka MX; Chandler DL; Beck RW; Crouch ER; Donahue S; Holmes JM; Lee K; Melia M; Quinn GE; Sala NA; Schloff S; Silbert DI; Wallace DK
    Ophthalmology; 2008 Mar; 115(3):577-584.e3. PubMed ID: 17996306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Dec; 130(12):1525-33. PubMed ID: 23229693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing for congenital nasolacrimal duct obstruction.
    Petris C; Liu D
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of nasolacrimal duct obstruction in children between 18 months and 4 years old.
    Kushner BJ
    J AAPOS; 1998 Feb; 2(1):57-60. PubMed ID: 10532369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital nasolacrimal duct obstruction: irrigation or probing?
    Kim YS; Moon SC; Yoo KW
    Korean J Ophthalmol; 2000 Dec; 14(2):90-6. PubMed ID: 11213741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
    Honavar SG; Prakash VE; Rao GN
    Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.
    ; Repka MX; Melia BM; Beck RW; Atkinson CS; Chandler DL; Holmes JM; Khammar A; Morrison D; Quinn GE; Silbert DI; Ticho BH; Wallace DK; Weakley DR
    J AAPOS; 2008 Oct; 12(5):445-50. PubMed ID: 18595756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.
    Repka MX; Chandler DL; Holmes JM; Hoover DL; Morse CL; Schloff S; Silbert DI; Tien DR;
    Arch Ophthalmol; 2009 May; 127(5):633-9. PubMed ID: 19433712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing for nasolacrimal duct obstruction with intravenous propofol sedation.
    Movaghar M; Kodsi S; Merola C; Doyle J
    J AAPOS; 2000 Jun; 4(3):179-82. PubMed ID: 10849396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dacryoendoscopy-assisted incision of Hasner's valve under nasoendoscopy for membranous congenital nasolacrimal duct obstruction after probing failure: a retrospective study.
    Li Y; Wei M; Liu X; Zhang L; Song X; Xiao C
    BMC Ophthalmol; 2021 Apr; 21(1):182. PubMed ID: 33866971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.